Table 1 Sociodemographic and clinical characteristics of study participants at baseline (n = 134)
From: Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis
Characteristic | n (%) or median (IQR) |
|---|---|
Age | 36 (31–43) |
Female | 57 (43) |
Black African race | 134 (100) |
BMI | 19.1 (17.9–21.8) |
Current smoker | 21 (16) |
Ever smoker | 53 (40) |
Pack-years of cigarettes | 2.8 (1.2–7.5) |
Chronic lung disease | 0 (0) |
History of mine work | 2 (1) |
HbA1c | 6.1 (5.8–6.4) |
CD4 cell count (cells/μl) | 110 (49–194) |
HIV viral load (copies/ml) | 146,742 (54,194–494,851) |
FEV1% predicted | 79 (66–89) |
FVC % predicted | 85 (73–95) |
FEV1/FVC ratio | 79 (73–85) |
Time from TB treatment to ART initiation (days) | 24 (15–42) |